Puration Inc (OTCMKTS: PURA) made a spectacular move up in October of last year from pennies to highs of $0.25 per share. Since than the stock has formed a new base in the $0.08 level where it contiues to hold strong.
PURA making big moves in the booming CBD space which continues to grow, research has cited tremendous growth including Hemp Business Journal, an industry market research publication which projects that the CBD market will reach $2.1 billion by 2020.
Puration Inc (OTCMKTS: PURA) first started off as as water purification Company before acquiring a patented cannabis extraction process. Initially focused on establishing itself as a supplier of the highest quality cannabis extract available PURA got into the booming CBD market and the rest is history. The Company now describes itself as a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow it product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business. Last month PURA announced it will spin-off its cannabis cultivation business. The prospective “spinoff” will be affected by selling the cannabis cultivation business to Nouveau Life Pharmaceuticals, Inc., (USOTC: NOUV)
The Company launched the EVERx CBD Infused Sports Waters in the spring of 2017 at Arnold Schwarzenegger’s Arnold Sports Festival. EVERx has since become the leading CBD infused beverage in the sports nutrition market place. The company’s sales grew 600% in the first year after the launch of EVERx. Kiwi Strawberry and Lemon Lime flavors are now available in addition to the Original EVERx CBD Infused Sports Water.
EVERx has more than twice the CBD of most CBD infused waters on the market. A proprietary technology enables EVERx to suspend more CBD than its competitors and still have a crystal-clear appearance and a refreshing taste. The company has recently initiated a package redesign after extensive market testing of a new logo design. Consumer demand for CBD infused beverages is growing and Puration is likewise receiving inquiries from a broader array of retail outlets. The package redesign is the first step of a comprehensive marketing plan to dramatically increase EVERx sales over the next 24 months.
Building on Puration’s success with the introduction of its EVERx CBD Infused Sports Water, Puration is reorganizing to concentrate its efforts on the cannabis beverage industry. The plan to concentrate on the cannabis beverage industry has been validated by global alcohol giant Constellation Brands’ (Corona Beer, among others) recent $4 billion investment in Canopy Growth.
To Find out the inside Scoop on PURA Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Earlier this month Goldman Small Cap Released a Research Report on PURA noting “PURA is one of the leading players in the fast-growing CBD-infused beverage arena. In fact, Puration’s flagship product has enjoyed 600% sales growth since its introduction in 2017. Leveraging this growth, Puration plans to execute M&A and introduce new beverage products. With double the number of CBDs found in most beverages, PURA’s EVERx CBD Infused Sports Waters reduce pain and muscle soreness.”
“Major beverage companies such as Constellation Brands, Coca-Cola have already begun joint venture with companies in the cannabis space or are devising their strategies. These recent events bode well for companies like Puration which has demonstrated sales and a strong customer base in the sports nutrition and fitness sector. To focus on its core, high-growth beverage business, PURA announced a spin-off of its cannabis cultivation segment, effective 10/11/18. This event could turn into a future bonus for shareholders.”
In December PURA reemphasized the company’s cannabis beverage industry experience and direction in light of the recently announced Anheuser Busch Inbev NV (NYSE:BUD) and Tilray Inc. (NASDAQ:TLRY) cannabis-infused beverage deal with both firms investing $50 million each to research potential beverage production. “Cannabis infused beverage industry interest heated up last year around Canada’s legalization of recreational marijuana,” said Brian Shibley, CEO of Puration. “Among other notable fortune 500 beverage industry announcements regarding interest in the cannabis beverage market, Puration got its tires kicked by a heavy weight.
Now with the US legalization of hemp farming, big beverage industry players are renewing their interest. While the big players invest money to explore potential cannabis infused beverage industry production, Puration has $1 million in cannabis infused beverage sales under its belt and has set a goal on ringing $5 million in sales next year. By the way, we’ve already experimented with hemp beer. I thought I’d mention that today in light of the Anheuser Busch announcement.” Puration recently released a 2018 year-end report detailing the company’s historical sales and 2019 sales goals. The report also includes new information on previously announced plans to issue a dividend of Nouveau Life Pharmaceuticals, (USOTC: NOUV) stock to PURA shareholders that will speed up the issuance in addition to, management believes, improving the overall value of the dividend. Management also includes in the update highlights of business developments with US Cannabis Health partners NOUV and Kali-Extracts.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $48 million market valuation PURA has $150k in the treasury, rising debt and fast growing sales recently reporting a 594% increase in revenue compared to the same period last year. PURA is an exciting story developing in small caps; the Company’s EVERx CBD Infused Sports Waters is the leading CBD infused beverage in the sports nutrition market place and the CBD market is booming. Currently NOUV is working to rapidly come current with its financial reports. Once NOUV is current, the company will initiate a recapitalization which will be followed by the previously announced PURA spin-off its cannabis cultivation business to Nouveau Life Pharmaceuticals, Inc., We will be updating on PURA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with PURA.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in PURA either long or short and we have not been compensated for this article.